Three top U.S. regulators are pressing banks of every size on AI agents, foreign tech and shutdown controls.

The chipmaker’s five-year pledge funds quantum, health and energy research at Argonne and Los Alamos as China’s LineShine leads global rankings.

Kennedy says AI chatbots can free Americans from “medical tyranny.” Grassroots allies and doctors aren't buying it.

Nationwide recall hits Amazon Basic Care Extra Strength caplets made in India after shoppers spotted discoloration.

Revolution Crossroads has already flagged 10,000 objects tied to everyday colonists from 1770 to 1810, linking a silversmith's ad to a museum creamer.

Top $TRUMP buyers can win a gala invite and an 18-karat watch — but no meet-and-greet is promised.

A Case Western Reserve study warns vascular surgery will meet just 65.8% of demand by 2038, with rural patients hit hardest.

Netlist wants federal regulators to block imports of Micron memory found in Google, Nvidia and Broadcom AI hardware.

Gates says people with bad intent, not runaway machines, pose AI's biggest near-term danger — and a kill switch alone won't stop it.

The AI startup, formerly Go Abacus, says it now processes 12.5 million queries a day for over 200 regulated clients.

1,643 pairs of the AI-powered glasses can receive a free firmware update.

An email titled Change in Nomenclature AI to SI landed in diplomats' inboxes after Trump told the U.N. that artificial makes intelligence sound fake.

Eli Lilly's Onswik trades daily insulin shots for one weekly dose, backed by trials in more than 3,400 adults with type 2 diabetes.